SEPN — Septerna, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1984086 ·
Last close
$40.02
Market Cap
$1.90B
52W High
$53.34
52W Low
$21.31
ADV30
429,915
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 18,881,000 | — | -27,229,000 | -26,590,000 | 619,404,000 | 167,124,000 | 191,475,000 |
| Jun 2026 | 26,746,000 | — | -16,836,000 | -13,034,000 | 566,737,000 | 84,662,000 | 180,016,000 |
| Mar 2026 | 26,523,000 | — | -13,300,000 | -8,637,000 | 569,688,000 | 71,605,000 | 191,230,000 |
| Dec 2025 | 24,118,000 | — | -16,023,000 | -10,738,000 | 596,187,000 | 120,722,000 | 214,261,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-76,568,000
Investing CF
$-157,223,000
Financing CF
$80,926,000
CapEx
$-1,037,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1.29
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-215,514,000
Inventory
—
Receivables
$21,879,000
ST Investments
$311,477,000
EBIT TTM
$-73,388,000
Pretax Income TTM
$-53,056,000
Interest Exp TTM
—
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$96,268,000
EBITDA
$-71,745,000
Free Cash Flow
$-7,808,500
Enterprise Value
$1,568,988,928
Total Cash
$478,600,992
Total Debt
$21,993,000
Shares Out
47,549,223
Trailing EPS
$-1.30
Book Value
$9.03
ROE
-14.4%
ROA
-7.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 45,951,000 | -80,797,000 | -48,879,000 | 596,187,000 | 214,261,000 | 381,926,000 | 110,189,000 |
| Dec 2024 | 1,075,000 | -80,823,000 | -71,798,000 | 456,554,000 | 36,507,000 | 420,047,000 | -67,470,000 |
| Dec 2023 | 151,000 | -45,550,000 | 4,180,000 | 130,867,000 | 169,241,000 | -38,374,000 | -38,723,000 |
| Dec 2022 | 0 | -27,967,000 | -27,676,000 | 36,119,000 | 80,320,000 | -44,201,000 | -23,303,000 |
TTM Snapshot
Revenues TTM
$98,882,000
NetIncome TTM
$-24,236,000
OpCashFlow TTM
—
Assets (Latest)
$566,737,000
Forward EPS
$-1.67
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | $1.89B | $26.20 | — |
| ZBIO | Zenas BioPharma, Inc. | $1.88B | $27.75 | — |
| TRVI | Trevi Therapeutics, Inc. | $1.93B | $13.51 | — |
| HMDCF | HUTCHMED (China) Ltd | $1.88B | $2.16 | — |
| HRMY | Harmony Biosciences Holdings, Inc. | $1.94B | $33.01 | — |
News headlines (Yahoo Finance, 1h cache)
Septerna (SEPN) Stock Sees Fair Value Lift As Analysts Raise SEP 479 Expectations
2026-11-13 03:17 · Yahoo
What Septerna Shares Profit To Loss Swing Means For Shareholders
2026-11-10 07:08 · Yahoo
Septerna, Inc. (SEPN) Reports Q3 Loss, Lags Revenue Estimates
2026-11-09 21:35 · Yahoo
Septerna Highlights Business Progress and Reports Third Quarter 2026 Financial Results
2026-11-09 21:01 · Yahoo
Septerna Announces Selection of SEP-204 as Development Candidate for Graves' Disease and TED and Reports Preclinical Data at the 2026 American Thyroid Association Annual Meeting
2026-11-04 13:00 · Yahoo
Septerna to Participate in Upcoming Investor Conferences
2026-11-03 13:00 · Yahoo
Is Septerna (SEPN) Stock Too Rich, Or Still Reasonable?
2026-10-28 20:07 · Yahoo
Septerna (SEPN) Heads To Healthcare Conferences, Is The Valuation Already Too Rich?
2026-09-14 14:10 · Yahoo
Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-09-10 20:00 · Yahoo
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer
2026-08-25 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.